Dr. med. Iris Polifka

Institute of Pathology

Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases (2023) Demleitner M, Erlenbach-Wünsch K, Coras R, Erber R, Polifka I, Eyüpoglu IY, Fuchs F, et al. Journal article Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma (2023) Mikuteit M, Zschäbitz S, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma (2023) Zundler S, Vitali F, Kharboutli S, Völkl S, Polifka I, Mackensen A, Atreya R, et al. Journal article Expression of nectin-4 in papillary renal cell carcinoma (2022) Zschabitz S, Mikuteit M, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy (2022) Buettner FA, Winter S, Stuehler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, et al. Journal article The prognostic impact of Claudin 6 in papillary renal cell carcinoma (2022) Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article cMET: a prognostic marker in papillary renal cell carcinoma? (2022) Erlmeier F, Bruecher B, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma. (2022) Mondorf Y, Mikuteit M, Ivanyi P, Stoehr C, Herrmann E, Polifka I, Agaimy A, et al. Journal article Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort (2022) Zschaebitz S, Erlmeier F, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Onkozytäre Tumoren der Niere – neue Differenzialdiagnosen (2021) Polifka I, Ohashi R, Moch H Journal article, Review article